Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC reported 18 holdings worth US$76M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Ally Bridge Group (NY) LLC reported 18 holdings worth US$76M as of Sep 30, 2026. Largest: Edgewise Therapeutics, Inc., ProMIS Neurosciences Inc. and Minerva Neurosciences, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
18
Value as reported
US$76M

The filing in full

CompanySharesValue as reported% of portfolio
Edgewise Therapeutics, Inc.185KUS$7.53M9.9%
ProMIS Neurosciences Inc.620KUS$6.73M8.9%
Minerva Neurosciences, Inc1.66MUS$5.55M7.3%
Amylyx Pharmaceuticals, Inc.182KUS$5.3M7.0%
Shattuck Labs, Inc.625KUS$4.26M5.6%
Obsidian Therapeutics, Inc.302KUS$4.15M5.5%
AN2 Therapeutics, Inc.526KUS$2.8M3.7%
Eupraxia Pharmaceuticals, Inc.231KUS$2.1M2.8%
Avalo Therapeutics, Inc.134KUS$2.06M2.7%
Inventiva SA227KUS$839K1.1%
Vogenx Inc32,701US$745K0.98%
Traws Pharma, Inc.786KUS$467K0.61%
Perspective Therapeutics, Inc.164KUS$450K0.59%
Assembly Biosciences, Inc.18,298US$430K0.57%
Climb Bio, Inc.0US$00.00%
CytomX Therapeutics, Inc.0US$00.00%
First Tracks Biotherapeutics, Inc.0US$00.00%
iBio, Inc.0US$00.00%
IDEAYA Biosciences, Inc.0US$00.00%
Kura Oncology, Inc.0US$00.00%
Ovid Therapeutics Inc.0US$00.00%
Palisade Bio, Inc.0US$00.00%
Solid Biosciences Inc.0US$00.00%
Whitehawk Therapeutics, Inc.0US$00.00%
Alumis Inc.0US$00.00%
Axsome Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related